Talk:Oroboros Laboratory: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__TOC__ | __TOC__ | ||
== Picked up - reading and discussion == | == Picked up - reading and discussion == | ||
=== As we go === | |||
* 2017-06-19 [[Gdynia_2016_Nat Commun]] - Malic enzyme; cancer | * 2017-06-19 [[Gdynia_2016_Nat Commun]] - Malic enzyme; cancer | ||
| Line 13: | Line 15: | ||
* 2017-05-22: [[Komlodi 2017 Neuropharmacology]] | * 2017-05-22: [[Komlodi 2017 Neuropharmacology]] | ||
=== Various === | |||
:::* [https://www.ncbi.nlm.nih.gov/pubmed/21664270 The rate of oxygen utilization by cells - interesting review beyond ascorbate topic] | ::::* [https://www.ncbi.nlm.nih.gov/pubmed/21664270 The rate of oxygen utilization by cells - interesting review beyond ascorbate topic] | ||
:::* [http://time.com/4475628/the-new-science-of-exercise/ The new science of exercise] | ::::* [http://time.com/4475628/the-new-science-of-exercise/ The new science of exercise] | ||
:::* [http://collections.plos.org/s/meta-research?utm_source=dfp&utm_medium=banner&utm_campaign=col-1604-metares Meta-research: Evaluation and improvement of research methods and practices] | ::::* [http://collections.plos.org/s/meta-research?utm_source=dfp&utm_medium=banner&utm_campaign=col-1604-metares Meta-research: Evaluation and improvement of research methods and practices] | ||
=== Warburg effect === | |||
::::* Warburg O | ::::* Warburg O (1956) On the origin of cancer cells. Science 123:309-14. | ||
::::* Warburg O | ::::* Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-70. | ||
::::* Vander Heiden MG, Cantley LC, Thompson CB | ::::* Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-33. | ||
::::* Kim JW, Dang CV | ::::* Kim JW, Dang CV (2006) Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 66:8927-30. | ||
::::* Review: http://online.liebertpub.com/doi/full/10.1089/ars.2016.6750 | ::::* Review: http://online.liebertpub.com/doi/full/10.1089/ars.2016.6750 | ||
::::* Review: http://onlinelibrary.wiley.com/doi/10.1111/febs.13402/full | ::::* Review: http://onlinelibrary.wiley.com/doi/10.1111/febs.13402/full | ||
| Line 28: | Line 30: | ||
== To our editors == | == To our editors == | ||
* [[OROBOROS Mitochondrial Research Laboratory]] was moved to [[OROBOROS MitoFit Laboratory]] | :::* [[OROBOROS Mitochondrial Research Laboratory]] was moved to [[OROBOROS MitoFit Laboratory]] | ||
:: >> Please check redirects from [[OROBOROS Mitochondrial Research Laboratory]] | :::: >> Please check redirects from [[OROBOROS Mitochondrial Research Laboratory]] | ||
* [[OROBOROS MitoLab: visiting scientists]] was moved to [[OROBOROS MitoFit lab: visiting scientists]] | :::* [[OROBOROS MitoLab: visiting scientists]] was moved to [[OROBOROS MitoFit lab: visiting scientists]] | ||
:: >> Please check redirects from [[OROBOROS MitoLab: visiting scientists]] | :::: >> Please check redirects from [[OROBOROS MitoLab: visiting scientists]] | ||
* Rationale: The 'MitoFit Centre of Excellence' or the 'MitoFit Core Facility' will be comprise of the OROBOROS MitoFit Laboratory and the DSL MitoFit Facility. | :::* Rationale: The 'MitoFit Centre of Excellence' or the 'MitoFit Core Facility' will be comprise of the OROBOROS MitoFit Laboratory and the DSL MitoFit Facility. | ||
Revision as of 09:22, 22 June 2017
Picked up - reading and discussion
As we go
- 2017-06-19 Gdynia_2016_Nat Commun - Malic enzyme; cancer
- 2017-06-08 Patent of Q-electrode (1988): Dr P.R. Rich, Glynn Res. Ph., Bodmin; European Patent no.85900699.1 Hungerm (talk) 10:18, 21 June 2017 (CEST)
- 2017-06-08 Pre-print publication: Mitochondria are physiologically maintained at close to 50 °C »Bioblast link«
- 2017-05-30 Quote of the day: ".. oligomycin (complex V inhibitor) determines the amount of ATP production is linked to respiration, FCCP (mitochondrial uncoupler) enables measurement of maximal respiratory capacity, while a combination of rotenone (complex I inhibitor) and antimycin A (complex III inhibitor) determines the reserved respiratory capacity." .. and more: "The mitochondrial network is a major site of ATP production through the coupled integration of the electron transport chain (ETC) with oxidative phosphorylation." - Trotta et al (2017) Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition. JBC Papers in Press. Published on May 25, 2017 as Manuscript M117.786442.
- What is reserved respiratory capacity?
- 2017-05-22: Komlodi 2017 Neuropharmacology
Various
Warburg effect
- Warburg O (1956) On the origin of cancer cells. Science 123:309-14.
- Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-70.
- Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-33.
- Kim JW, Dang CV (2006) Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 66:8927-30.
- Review: http://online.liebertpub.com/doi/full/10.1089/ars.2016.6750
- Review: http://onlinelibrary.wiley.com/doi/10.1111/febs.13402/full
To our editors
-
- >> Please check redirects from OROBOROS Mitochondrial Research Laboratory
-
-
- >> Please check redirects from OROBOROS MitoLab: visiting scientists
-
- Rationale: The 'MitoFit Centre of Excellence' or the 'MitoFit Core Facility' will be comprise of the OROBOROS MitoFit Laboratory and the DSL MitoFit Facility.
